Research & Development



  “司馬相如不會死于雲瑯之手,你信不信?”   加入忽略掉他身為中年人的沉穩氣息,以及久居高位帶來的壓迫感,他依舊是一個美少年。偷拍久久国产视频   雲哲對于這位經常可以看到的皇帝並沒有多少畏懼之心,听皇帝說的話跟父母親交代的不一樣,就大聲道︰“我耶耶說過,做錯了,就做錯了,只要是錯事,就一定會留下痕跡,如果能有挽回錯誤的機會,就一定不要錯過。”曰本高清一本道无码av   劉徹听阿嬌這樣說立刻來了興趣,瞅著院子里的兩個孩子興奮地問道︰“誰家的話語權?”   金日嘆口氣道︰“人家看不起我就看不起我,嘴上說兩句就說兩句,你這麼暴躁做什麼?”我被农民工大jb插   霍光立刻把剩余的半個包子塞嘴里,就隨著雲音匆匆的跑了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo